CN113518804A - 一种用于3d打印的墨水材料、制备方法及用途 - Google Patents
一种用于3d打印的墨水材料、制备方法及用途 Download PDFInfo
- Publication number
- CN113518804A CN113518804A CN201980077907.9A CN201980077907A CN113518804A CN 113518804 A CN113518804 A CN 113518804A CN 201980077907 A CN201980077907 A CN 201980077907A CN 113518804 A CN113518804 A CN 113518804A
- Authority
- CN
- China
- Prior art keywords
- ink
- printing
- zein
- ethanol
- printing according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010146 3D printing Methods 0.000 title claims abstract description 67
- 239000000463 material Substances 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 229920002494 Zein Polymers 0.000 claims abstract description 53
- 239000005019 zein Substances 0.000 claims abstract description 53
- 229940093612 zein Drugs 0.000 claims abstract description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 210000001519 tissue Anatomy 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 230000000740 bleeding effect Effects 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 230000001788 irregular Effects 0.000 claims description 4
- 235000002639 sodium chloride Nutrition 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 210000005036 nerve Anatomy 0.000 claims description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 2
- 208000009344 Penetrating Wounds Diseases 0.000 claims description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 2
- 239000001099 ammonium carbonate Substances 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 210000000845 cartilage Anatomy 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- 239000001433 sodium tartrate Substances 0.000 claims description 2
- 229960002167 sodium tartrate Drugs 0.000 claims description 2
- 235000011004 sodium tartrates Nutrition 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 210000003437 trachea Anatomy 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 229940030225 antihemorrhagics Drugs 0.000 claims 1
- 239000002473 artificial blood Substances 0.000 claims 1
- 239000003519 biomedical and dental material Substances 0.000 claims 1
- 230000000025 haemostatic effect Effects 0.000 claims 1
- 238000010422 painting Methods 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 26
- 238000007639 printing Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 15
- 239000000499 gel Substances 0.000 description 12
- 239000002994 raw material Substances 0.000 description 10
- 238000009210 therapy by ultrasound Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000029549 Muscle injury Diseases 0.000 description 2
- 206010040860 Skin haemorrhages Diseases 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/04—Printing inks based on proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/03—Printing inks characterised by features other than the chemical nature of the binder
- C09D11/033—Printing inks characterised by features other than the chemical nature of the binder characterised by the solvent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Surgery (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Materials For Medical Uses (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Abstract
本发明涉及一种用于3D打印的墨水、制备方法及墨水的用途。该墨水是由α玉米醇溶蛋白,玉米蛋白重量0‑0%的制孔剂,乙醇和水组成的凝胶。该制备方法包括:把10~50%重量的玉米醇溶蛋白溶解在含有40~90%(v/v)乙醇的水溶液中,加入玉米蛋白重量0‑10%的制孔剂,在5~95℃恒温静置1~10天或者搅拌30分钟‑24小时后,获得可用于3D打印的墨水材料。该方法条件温和、操作简单,所述的3D打印的墨水的力学性能和生物相容性好。可用于生物医学领域,在室温下3D打印制备组织工程替代物和止血材料。
Description
PCT国内申请,说明书已公开。
Claims (12)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/070746 WO2020142888A1 (zh) | 2019-01-08 | 2019-01-08 | 一种用于3d打印的墨水材料、制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113518804A true CN113518804A (zh) | 2021-10-19 |
CN113518804B CN113518804B (zh) | 2022-12-06 |
Family
ID=71520609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980077907.9A Active CN113518804B (zh) | 2019-01-08 | 2019-01-08 | 一种用于3d打印的墨水材料、制备方法及用途 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220154018A1 (zh) |
JP (1) | JP7372976B2 (zh) |
CN (1) | CN113518804B (zh) |
WO (1) | WO2020142888A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024045431A1 (zh) * | 2022-08-29 | 2024-03-07 | 上海交通大学 | 玉米醇溶蛋白原纤维粉末、玉米醇溶蛋白新凝胶及其制备方法和应用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113351268A (zh) * | 2021-06-18 | 2021-09-07 | 华南理工大学 | 一种基于3d打印的同轴微流控芯片及其制备方法 |
CN113523627B (zh) * | 2021-09-17 | 2021-12-10 | 江苏新恒基特种装备股份有限公司 | 一种增材制造温度测控装置、系统及方法 |
WO2023200731A1 (en) * | 2022-04-11 | 2023-10-19 | Rose Daniel Todd | Foamable thermoplastic compositions for 3d printing |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1555892A (zh) * | 2004-01-08 | 2004-12-22 | 上海交通大学 | 植物源性醇溶蛋白三维支架的制备方法 |
CN104210162A (zh) * | 2014-08-26 | 2014-12-17 | 华南理工大学 | 一种高度疏水可食用膜的制备方法 |
US20170218228A1 (en) * | 2014-07-30 | 2017-08-03 | Tufts University | Three Dimensional Printing of Bio-Ink Compositions |
CN107496994A (zh) * | 2017-09-19 | 2017-12-22 | 云智前沿科技发展(深圳)有限公司 | 一种基于3d打印的术后药物缓释支架及其制备方法 |
CN107595809A (zh) * | 2017-09-19 | 2018-01-19 | 云智前沿科技发展(深圳)有限公司 | 一种玉米醇溶蛋白纳米包埋缓释填充物及其制备方法 |
CN109021259A (zh) * | 2018-06-20 | 2018-12-18 | 东北农业大学 | 玉米醇溶蛋白-纤维核胶体颗粒的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3374659D1 (en) * | 1983-02-03 | 1988-01-07 | Ethicon Inc | Paste for hemostasis and for temporary relief of defects in the traumatism of bones |
JP2002179971A (ja) * | 2000-12-18 | 2002-06-26 | Toyo Ink Mfg Co Ltd | 印刷インキ |
FR2885619B1 (fr) * | 2005-05-13 | 2011-02-11 | Imaje Sa | Composition d'encre liquide, alimentaire, ingerable pour l'impression par jet d'encre |
CN108912700A (zh) * | 2018-08-09 | 2018-11-30 | 云智前沿科技发展(深圳)有限公司 | 一种具有生物光电双重功能的复合材料及制备方法与应用 |
-
2019
- 2019-01-08 JP JP2021539145A patent/JP7372976B2/ja active Active
- 2019-01-08 CN CN201980077907.9A patent/CN113518804B/zh active Active
- 2019-01-08 US US17/421,115 patent/US20220154018A1/en active Pending
- 2019-01-08 WO PCT/CN2019/070746 patent/WO2020142888A1/zh active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1555892A (zh) * | 2004-01-08 | 2004-12-22 | 上海交通大学 | 植物源性醇溶蛋白三维支架的制备方法 |
US20170218228A1 (en) * | 2014-07-30 | 2017-08-03 | Tufts University | Three Dimensional Printing of Bio-Ink Compositions |
CN104210162A (zh) * | 2014-08-26 | 2014-12-17 | 华南理工大学 | 一种高度疏水可食用膜的制备方法 |
CN107496994A (zh) * | 2017-09-19 | 2017-12-22 | 云智前沿科技发展(深圳)有限公司 | 一种基于3d打印的术后药物缓释支架及其制备方法 |
CN107595809A (zh) * | 2017-09-19 | 2018-01-19 | 云智前沿科技发展(深圳)有限公司 | 一种玉米醇溶蛋白纳米包埋缓释填充物及其制备方法 |
CN109021259A (zh) * | 2018-06-20 | 2018-12-18 | 东北农业大学 | 玉米醇溶蛋白-纤维核胶体颗粒的制备方法 |
Non-Patent Citations (1)
Title |
---|
徐琴等: "玉米醇溶蛋白动物体内植入后的免疫学分析方法初探", 《现代生物医学进展》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024045431A1 (zh) * | 2022-08-29 | 2024-03-07 | 上海交通大学 | 玉米醇溶蛋白原纤维粉末、玉米醇溶蛋白新凝胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2020142888A1 (zh) | 2020-07-16 |
CN113518804B (zh) | 2022-12-06 |
US20220154018A1 (en) | 2022-05-19 |
JP2022525269A (ja) | 2022-05-12 |
JP7372976B2 (ja) | 2023-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113518804B (zh) | 一种用于3d打印的墨水材料、制备方法及用途 | |
EP1938774B2 (en) | Medical artificial nerve graft containing silk fibroin and its preparation method | |
US20220202989A1 (en) | Thermosensitive chitosan hydrogel composition and bioink composition comprising the same | |
CN106310380B (zh) | 一种纳米纤维化丝素蛋白凝胶及其制备方法 | |
CN101544767B (zh) | 生物相容性高强度三维连通多孔pva水凝胶的制备方法 | |
CN101716366A (zh) | 醛改性海藻酸钠和胺改性明胶的生物胶型止血剂 | |
CN110665061A (zh) | 一种脱细胞支架溶液-GelMA水凝胶复合材料及制备方法 | |
CN106178106A (zh) | 3d打印海藻酸钠/聚乙烯醇全物理交联双网络水凝胶支架的方法 | |
CN104004221B (zh) | 一种聚己内酯‑角蛋白复合多孔支架的制备方法 | |
CN112920425B (zh) | 医用水凝胶组合物,医用水凝胶及其制备方法 | |
CN110075359B (zh) | 一种超声辅助制备多孔骨水泥支架及其制备方法 | |
CN109646720B (zh) | 一种用于3d打印的水凝胶复合材料及其制备方法和应用 | |
CN110075361A (zh) | 一种高强度高韧性软骨支架的制备方法 | |
US20230357712A1 (en) | A sodium alginate, gelatin, collagen and fibrin (agcf) based bio-ink for the bioprinting of a 3d biogel-based tissue/structure | |
CN103083729A (zh) | 一种三维多孔复合棒材的制备方法 | |
CN102133432B (zh) | 一种丝素蛋白微孔支架的制备方法 | |
Taneja et al. | Hydrogel based 3D printing: Bio ink for tissue engineering | |
JP2022527533A (ja) | ゼラチンおよびその用途 | |
TW477802B (en) | Method for preparing hydrophilic porous polymeric materials | |
CN105920680B (zh) | 一种软组织工程多孔支架及其制备方法 | |
CN110859994B (zh) | 一种改性柞蚕丝素蛋白3d打印支架及其制备方法 | |
CN107376005A (zh) | 一种生物可降解医用止血纸及其制备方法 | |
CN105860151A (zh) | 注射用高分子普鲁兰多糖-胶原蛋白复合水凝胶及其制备方法 | |
CN111803714B (zh) | 一种综合酸-碱溶剂体系的壳聚糖骨修复支架及其制备方法 | |
CN109880152B (zh) | 取向连通多孔生物医用支架的制备方法及其制备的支架和该支架在制备医疗产品中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |